| Literature DB >> 32557631 |
Hossein Abbaszadeh1,2, Farzaneh Ghorbani1,2, Mehdi Derakhshani1,2, Ali Akbar Movassaghpour3, Mehdi Yousefi4, Mehdi Talebi5, Karim Shamsasenjan2.
Abstract
Umbilical cord Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) have recently gained considerable attention in the field of regenerative medicine. Their high proliferation rate, differentiation ability into various cell lineages, easy collection procedure, immuno-privileged status, nontumorigenic properties along with minor ethical issues make them an ideal approach for tissue repair. Besides, the number of WJ-MSCs in the umbilical cord samples is high as compared to other sources. Because of these properties, WJ-MSCs have rapidly advanced into clinical trials for the treatment of a wide range of disorders. Therefore, this paper summarized the current preclinical and clinical studies performed to investigate the regenerative potential of WJ-MSCs in neural, myocardial, skin, liver, kidney, cartilage, bone, muscle, and other tissue injuries.Keywords: Wharton's jelly; mesenchymal stem cells; regenerative medicine; umbilical cord
Mesh:
Year: 2020 PMID: 32557631 DOI: 10.1002/jcp.29810
Source DB: PubMed Journal: J Cell Physiol ISSN: 0021-9541 Impact factor: 6.384